ABSTRACT
depletion of IFI35 led to reduced VSV replication at the level of viral gene expression.
23
Although no direct interaction of IFI35 with the viral replication machinery was observed, 24 we found that IFI35 negatively regulated the host innate immune response and rescued Specifically, we found that IFI35 inhibited activation of the RNA sensor, the retinoic acid domain that lacks the basic region essential for DNA binding but can homo-and hetero-69 dimerize with its binding partners through the N-myc interacting domains (NIDs) (9, 10).
70
It also interacts with another ISG called N-myc interacting protein (Nmi) to form a 200-71 400 kDa high molecular mass complex (HMMC) in response to IFN-α treatment (10).
72
The interaction of IFI35 with Nmi prevents IFI35 from proteasomal degradation (11). 
75
In contrast to the classical role of ISGs in antagonizing virus infections, several
76
ISGs are known to play regulatory functions to control excessive antiviral signaling.
77
Recently, ISGs such as ISG56, Optineurin, gC1qR, LGP2 and SARM have been shown 
106
In this report, we have investigated the supportive role of IFI35 in VSV infection.
107
Our studies reveal that IFI35 functions as a negative regulator of the host antiviral transfected with an empty vector was also generated and used in control experiments.
124
Following isolation, the stable cells were maintained in complete media containing G418
125
(250 µg/ml). G418 was purchased from Invitrogen, MG132, poly(I:C) and calyculin A 126 were purchased from Sigma Aldrich. constructs were sequence verified and all the primers used are described in Table 1 . Table 1 . Statistical analysis. Statistical significance between groups was determined by two-225 tailed paired Student's t test. p < 0.05 was considered statistically significant.
226

RESULTS
227
Depletion of IFI35 inhibits VSV replication 228 Our recent genome-wide RNAi screen identified IFI35 as a factor required for 229 VSV infection (7) . Since IFI35 is an ISG, it was intriguing to observe its requirement in 
237
A 4-6 fold reduction in VSV M protein levels (measure of virus replication) was observed 238 in cells depleted of IFI35 (Fig. 1A) . Depletion of IFI35 also reduced VSV progeny 239 production significantly (Fig. 1B) . These data reconfirmed our genome-wide screening 240 results and suggested that IFI35 is required for VSV replication and growth. Fig. 2A) . Additionally, we observed that when HEK293 cells were 278 depleted of IFI35 using siRNAs, IFNβ mRNA levels were increased significantly ( (Fig. 2C) . Collectively,
284
the results suggest that IFI35 down-regulates the host antiviral response.
285
The observation that depletion of IFI35 potentiated the production of IFNβ and promoter. Under these conditions, we observed a 4-fold increase in the luciferase 301 activity in IFI35 depleted cells compared to control (Fig. 3A) . In SeV-infected 3xF-IFI35 302 stable cells, significant (5-fold) reduction in luciferase activity was observed compared 303 to Sev-infected EV cells (Fig. 3B) . These data suggest that IFI35 down-regulates the
304
IFNβ promoter induction, providing further support for our earlier observation on 305 reduced IFNβ mRNA levels ( Fig. 2A and 2B) . Next, we examined the effect of IFI35 on 306 induction of NF-κB promoter. We found only a 2-fold increase or decrease in NF-κB 307 dependent promoter activity when IFI35 was depleted or overexpressed, respectively, in 308 SeV-infected cells (Fig. 3C and 3D ), suggesting that NF-κB pathway may not play a 309 major role in IFI35-mediated down-regulation of IFNβ activation. Since we observed that 310 IFI35 overexpression suppressed ISG56 protein induction (Fig. 2C) , we then examined 311 if this suppression was due to down-regulation of ISG56 promoter activity. We found 312 about 5-fold enhancement in ISG56 promoter induction in cells depleted of IFI35 (Fig.   313   3E ) and a similar reduction (6-fold) in reporter activity was observed in cells 314 overexpressing IFI35 as compared to the control (EV) cells (Fig. 3F) . Taken together, 315 these results suggest that IFI35 down-regulates IFNβ activation pathway. (Fig. 4A) . Furthermore, IRF-3 phosphorylation was strongly suppressed in 3xF-IFI35 331 stable cells when infected with SeV (Fig. 4B) . As phosphorylation of IRF-3 leads to its 
335
Infection of EV cells with SeV led to translocation of IRF-3-GFP from the cytoplasm into 336 the nucleus whereas the nuclear translocation was abolished in 3xF-IFI35 stable cells 337 (Fig. 4C) . These results indicate that IFI35 inhibits the activation of IRF-3, which likely 338 accounts for the down-regulation of IFNβ promoter induction.
339
Since IRF-7 in most cells other than plasmacytoid dendritic cells is induced upon (Fig. 4D ) and reduced when IFI35 was 344 overexpressed (Fig. 4E) . Taken together, these results suggest that IFI35 negatively 345 regulates activation of IRF-3 and IRF-7. Thus, the down-regulation of IFNβ promoter is 346 likely due to the combined effect of suppression IRF-3 and IRF-7 activation.
347
IFI35 negatively regulates RIG-I pathway activation
348
To investigate if IFI35 down-regulates the antiviral signaling pathway upstream of (Fig. 5B) , whereas no 357 significant effect was observed with MAVS and TBK1 expression in these cells (Fig. 358 5B). These data suggest that IFI35 negatively regulates the host antiviral pathway by 359 exerting its effect at the level of RIG-I.
360
To understand how IFI35 regulates the activity of RIG-I, we examined the we observed significantly reduced phosphorylated form of RIG-I by using Ser8 364 phospho-specific RIG-I antibody (Fig. 5C ). The total RIG-I levels were also slightly 365 increased. In contrast, the level of RIG-I phosphorylation was partially restored in 3xF-
366
IFI35 stable cells infected with SeV and the total RIG-I was also reduced, indicating that 367 IFI35 overexpression led to suppression of RIG-I activation (Fig. 5D ). Since we 368 observed changes in total RIG-I levels by depletion or overexpression of IFI35, we 369 examined if IFI35 affected RIG-I induction at the level of transcription. Results showed 370 that RIG-I mRNA was up-regulated in cells depleted of IFI35 (Fig. 5E) , whereas in 3XF-
371
IFI35 stable cells, it was reduced (Fig. 5F ). Since RIG-I is an ISG, the reduced levels of 372 RIG-I mRNA may be due to overall down-regulation of IFNβ activation. These results
373
indicate that IFI35 down-regulates the activation of RIG-I, leading to overall suppression 374 of the antiviral response.
375
IFI35 interacts with and promotes RIG-I degradation via K48-linked ubiquitination
376
To further understand the mechanism by which IFI35 negatively regulates RIG-I 377 activation, we examined if IFI35 and RIG-I co-localize and/or interact in cells. We were subjected to co-IP with Flag (Fig. 6B, left panel) or HA (Fig. 6B, right decreased, indicating that the expressed HA-Ub-K48 was being conjugated to RIG-I.
400
Concomitant reduction of RIG-I levels was observed in the whole cell lysates (Fig. 6D) .
401
Further, we observed reduction in K48-linked ubiquitination of RIG-I when IFI35 was 402 depleted using siRNAs (Fig. 6E) . These data suggest that IFI35 interacts with RIG-I and (Fig. 7) .
466
Another mechanism of RIG-I inactivation by IFI35 appears to be through 
